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Macrophage receptors function in pattern recognition for the induction of innate immunity, in cellular
communication to mediate the regulation of adaptive immune responses, and in the clearance of some
glycosylated cells or glycoproteins from the circulation. They also function in homeostasis by initiating the
engulfment of apoptotic cells. Evidence has suggested that macrophage receptors function to recognize cells
that are destined for programmed cell death but not yet overtly apoptotic. We have examined the function of
a macrophage receptor specific for unsialylated glycoproteins, known as the mouse macrophage galactose- and
N-acetylgalactosamine-specific lectin (mMGL) (Ii et al., J. Biol. Chem. 265:11295-11298, 1990; Sato et al.,
J. Biochem. [Tokyo] 111:331-336, 1992; Yamamoto et al., Biochemistry 33:8159-8166, 1994). With targeted
disruption, we tested whether mMGL is necessary for macrophage function, controlled thymic development,
the loss of activated CD8 T cells, and the turnover of red blood cells. Evidence indicates that mMGL may play
a nonessential role in several of these macrophage functions. Experiments are presented that indicate the
existence of another galactose- and N-acetylgalactosamine-recognizing lectin distinct from mMGL. This may
explain the absence of a strong phenotype in mMGL-deficient mice.
Differential sialylation is a general property of hematopoietic cell development, including lymphocytes and erythrocytes.
For example, at a distinct stage in thymic development, several
abundant cell surface glycoproteins, such as CD8, CD43, and
CD45, are undersialylated, thus exposing terminal O-linked
Gal␤1-3GalNAc, a ligand for the lectin peanut agglutinin
(PNA). T-cell precursors migrate to the thymus as PNAlo
CD4⫺ CD8⫺ (double negative [DN]) cells (24, 38) and make
the transition to PNAhi cortical CD4⫹ CD8⫹ (double positive
[DP]) cells (5, 18, 19, 25–27). Upon differentiation, the DP
thymocytes progress to CD4 or CD8 lineage cells, migrate to
the medulla, and once again become PNAlo.
The extent of terminal Gal␤1-3GalNAc exposure inversely
correlates with the expression of ST3Gal-I, a Gal␤1-3GalNAcspecific ␣2,3 sialyltransferase that is expressed primarily in
medullary but not cortical thymocytes (3, 10). Upon expression
of ST3Gal-I, Gal␤1-3GalNAc becomes sialylated, preventing
PNA binding on these cells (23). Additionally, T cells become
increasingly sialylated on N-linked Gal␤1-4GlcNAc as they
transit from DP to single-positive (SP) cells (36). This latter
sialylation is thought to involve multiple sialyltransferases (7,
35).
Naive PNAlo T cells once again become PNAhi upon mito-

gen- or antigen-mediated activation (8, 30). Effector T cells
reveal terminal Gal␤1-3GalNAc, possibly through the action
of endogenous sialidases (8). The deletion of ST3Gal-I causes
all T cells to remain PNA positive and thus undersialylated on
several O-linked glycoproteins. The phenotypic effect of an
ST3Gal-I deficiency was a loss of CD8 T cells in the peripheral
lymphoid organs via apoptosis (23). The conclusion from these
studies was that regulated sialylation plays a role in the homeostatic maintenance of CD8 T cells.
Mouse macrophage galactose- and N-acetylgalactosaminespecific C-type lectin (mMGL) is a macrophage-specific, calcium-dependent C-type lectin whose carbohydrate recognition
domain has been shown to have high affinity for glycoproteins
bearing terminal galactose (Gal) and N-acetylgalactosamine
(GalNAc) sugars (39). This lectin is also known as the macrophage asialoglycoprotein-binding protein by the group that
cloned the gene from the rat (12). mMGL binding is inhibited
by sialylation (39). It is expressed on a subpopulation of macrophages present in most tissues (20), and it has been implicated in macrophage tumoricidal ability, phagocytosis, and endocytosis (11, 15). mMGL expression is also upregulated
during cardiac allograft rejection (28). Currently, the physiological role of mMGL remains uncertain.
Based on the expression of mMGL in the thymus and peripheral lymphoid organs and the existence of cells bearing
potential ligands for this terminal Gal/GalNAc-specific lectin,
we examined the role of mMGL-bearing cells in the regulation
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and turnover of lymphocytes during development and activation. In this report we describe the generation of mice that are
deficient for mMGL. An analysis of these mice revealed that
the loss of mMGL did not affect lymphoid differentiation or
immune function. Further, red blood cell turnover and life
span are minimally affected. We also show that mMGL is not
the only Gal/GalNAc-specific lectin expressed by mouse macrophages, and its inhibition does not substantially complement
the ST3Gal-I deficiency. We conclude from these studies that
mMGL plays a role in T-cell and erythrocyte homeostasis but
that there are other macrophage lectins with redundant or
overlapping functions.
MATERIALS AND METHODS
Flow cytometry. Cells were labeled with the following monoclonal antibodies
and reagents: anti-CD4-phycoerythrin (PE), anti-CD8-TC (CalTag), anti-CD5fluorescein isothiocyanate (FITC), anti-CD3-FITC, anti-heat-stable antigen–biotin, anti-CD44-PE, anti-CD25-biotin or -FITC, anti-CD62L-PE (all from
Pharmingen), PNA-FITC, and Erythrina cristigalli agglutinin-biotin (Sigma
Chemical Co., St. Louis, Mo.). Apoptotic cells were detected with annexin
V-FITC (CalTag), or terminal deoxynucleotidyltransferase-mediated dUTP-biotin nick-end labeling (Boehringer Mannheim). Samples were analyzed with a
FACSCAN or FACSCalibur (Becton Dickinson) and CellQuest software.
Genomic mapping and knockout construct. Exons 2 and 3 encoding the translational start site, cytoplasmic domain, and the transmembrane domain of
mMGL were mapped from genomic clones isolated from a strain 129SvJ library
(Stratagene, La Jolla, Calif.). The probe used was a mouse full-length mMGL
cDNA isolated from a subtractive hybridization experiment and identified by
sequence as previously published (3). These exons were replaced with the pPGKneobpA cassette (32), resulting in a targeting construct consisting of a 1.5-kb and
a 4-kb arm to mediate homologous recombination. The construct was transfected
into R1 embryonic stem (ES) cells (129 strain), and 700 G418-resistant colonies
were screened for homologous recombinants. One clone, H1, was identified and
injected into C57BL/6 blastocysts. Male mice obviously chimeric by coat color
were crossed to C57BL/6J females to obtain F1 heterozygotes, which were then
incrossed to obtain F2 mice homozygous for the deficient mMGL allele.
Immunohistochemistry. Tissues were collected from mice, frozen in OCT
(VWR Scientific), and kept at ⫺70°C until sectioned on a cryostat. Sections were
acetone fixed, washed in Tris-buffered saline, and blocked with 2% bovine serum
albumin. Biotinylated and unbiotinylated polyacrylamide arrays carrying multiple copies of Gal␤1-3GalNAc and Gal␣1-3GalNAc were purchased from Glycotech (Rockville, Md.). Antifreeze glycoprotein (AFGP; Sigma Chemical Company) was biotinylated with a biotinylation kit (Sigma Chemical Company). Rat
anti-mouse mMGL monoclonal antibody LOM-14 (13) was prepared as previously described. Biotinylated anti-Mac-1 and FITC-conjugated anti-Mac-1 were
purchased from BD Pharmingen.
Sections were incubated with primary reagents at room temperature for at
least 1 h, washed, and incubated for 30 min with secondary goat anti-rat alkaline
phosphatase (Jackson Immunochemicals). Sections were then developed with
alkaline phosphatase substrate and Vector Blue, and nuclei were counterstained
with Nuclear Fast Red (Vector Labs, Burlingame, Calif.). Alternatively, primary
biotinylated reagents were developed with fluorescently tagged streptavidin or
streptavidin-alkaline phosphatase.
Fibroblasts expressing mMGL. Full-length mMGL cDNA was subcloned into
pcDNA3 (Invitrogen, Carlsbad, Calif.) and transfected into 3T6 fibroblasts with
Polybrene as described before (21). G418-resistant clones were tested for mMGL
expression with flow cytometry and Northern analysis. Positive clones were
subcloned by limiting dilution. Transfected fibroblasts were seeded into 24-well
plates at 105 cells/well overnight.
Peritoneal macrophages. Littermates aged 4 to 8 months were challenged with
1 ml of 3% thioglycollate intraperitoneally, and 4 days later peritoneal cells were
isolated by lavage with 10 ml of cold Hanks’ balanced salt solution. Cells were
washed, counted, and stained for Mac-1. Cells were resuspended in RPMI
medium, seeded with 106 Mac-1⫹ cells to form monolayers, and allowed to
adhere to wells for 2 to 4 h. Nonadherent cells were vigorously washed with
medium.
In vitro coculture. Thymocytes were explanted from C57BL/6 mice and cultured as described above. Thymocytes (4 ⫻ 106 to 5 ⫻ 106) were added to
triplicate wells containing monolayers of macrophages or fibroblasts in 1 ml of

FIG. 1. Targeted deletion of mMGL exons 2 and 3 results in mice
deficient for mMGL. (A) Genomic mapping of the mMGL aminoterminal cytoplasmic and transmembrane domains revealed a ⬇1.0-kb
HindIII fragment encoding exons 2 and 3 which was targeted for
deletion with replacement vector pPGKneo (23). (B) Tail DNA from
F2 mice digested with HindIII and probed with an upstream genomic
probe revealed an endogenous 10.5-kb fragment and the recombinant
12-kb fragment. (C) Northern analysis of mMGL mRNA in mMGL⫹/⫺
and mMGL⫺/⫺ mice. GAPDH, glyceraldehyde-3-phosphate dehydrogenase. H, HindIII; S, SacI; R, EcoRI; Bx, BstXI; B, BamHI; N, NotI.

medium for 16 to 18 h. After vigorous washing, 0.2 ml from each well was stained,
counted, and analyzed by flow cytometry to determine live cell recovery. Recovery was calculated by multiplying the fraction of nonapoptotic cells (annexin V⫺)
of a specific subset by the total number of cells recovered.
CTL assay. Cytotoxic T lymphocyte (CTL) assays were performed as previously described (23). Briefly, mice were injected with 2 ⫻ 106 P815 tumor cells
intraperitoneally. On day 10, spleens and mesenteric lymph nodes were isolated
from mice, and lymphocytes were counted. Lymphocytes were added to 96-well
V-bottomed plates containing 51Cr-labeled specific target cells (P815) or nonspecific targets (EL-4) at various effector-to-target cell ratios. Cells were incubated for 4 h with targets, and 51Cr release was measured.
Determination of erythrocyte life span. To determine the life span of erythrocytes, mMGL-deficient mice and control littermates were biotinylated in vivo
with N-hydroxysuccinimido-biotin (NHS-biotin) (Sigma, St. Louis, Mo.) as described previously (1). Briefly, NHS-biotin was dissolved in dimethyl sulfoxide
(Aldrich, Milwaukee, Wis.) and diluted 1:10 with phosphate-buffered saline
(PBS) (Sigma) to a final concentration of 4 mg/ml, and 150 l of the final
solution was injected into the tail vein. The injection was repeated 1 h later.
Blood from biotinylated mice was taken at 1-week intervals, and 50 l of blood
was washed with 2 ml of PBS supplemented with 2% fetal calf serum and 1 mM
EDTA to remove biotinylated plasma proteins. Triplicate samples containing 15
l of blood cells were stained with 0.5 g of streptavidin-PerCP (Pharmingen,
San Diego, Calif.) at room temperature for 30 min. The percentage of labeled
erythrocytes was determined by flow cytometry, and the disappearance of the
cells over time was used to determine the erythrocyte life span for each mouse.

RESULTS
ⴚ/ⴚ

Generation of mMGL
mice. To understand the physiological role of mMGL in vivo, we targeted mMGL for germ
line deletion in mice. Since mMGL is a type II transmembrane
protein, we mapped the N-terminal transmembrane domain
and targeted exons 2 and 3 for replacement with a neomycin
resistance cassette with the vector pPGKneo (Fig. 1A). Homologous recombinants in ES cells could be identified by a
⬇12-kb HindIII recombinant fragment, compared to a
⬇10.5-kb endogenous fragment when probed with an upstream genomic probe. Of 700 G418-resistant ES clones examined by Southern blot analysis, one clone revealed the expected
recombinant allele, and this clone was injected into blastocysts.
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FIG. 2. Localized expression of mMGL in mouse tissues. Tissue
sections from mMGL⫹/⫹ and mMGL⫺/⫺ mice were stained with rat
immunoglobulin (Ig) control or monoclonal anti-mMGL antibodies
and compared to Mac-1 staining in each tissue. (A) Cytospin of peritoneal exudate cells. (B) Thymus. Note that cells staining for mMGL
in wild-type (WT) mice were seen predominantly in the corticomedullary junction and medulla. (C) Spleen, showing sparse staining of
mMGL staining compared to that in skin (D), lymph node (E), and
lung (F).

The resulting chimeric mice passed the deficient allele to the
first-generation progeny (Fig. 1B). Homozygous deficient mice
were deficient for mMGL by Northern (Fig. 1C) as well as by
reverse transcription-PCR analysis (data not shown).
mMGL expression. In order to verify the absence of mMGL
expression in mMGL⫺/⫺ mice and further characterize mMGL
expression in different tissues, immunohistochemistry was carried out with anti-mMGL monoclonal antibody (LOM14). Figure 2A depicts the staining from a cytospin of peritoneal exudate cells. As shown, a large percentage of peritoneal exudate
cells from wild-type mice were strongly mMGL positive. The
staining of peritoneal exudate cells from mMGL⫺/⫺ mice was
greatly diminished, although, with purified antibody, we did
detect residual staining over the rat immunoglobulin background.
We also compared the expression of mMGL to that of
Mac-1 in thymus, spleen, lymph node, skin, and lung from
wild-type and mMGL-deficient mice. In the thymus, we found
medullary staining in the wild-type mouse that was again reduced in the thymuses from mMGL⫺/⫺ mice (Fig. 2B). This
pattern of medullary staining is intriguing because the thymo-
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FIG. 3. mMGL null mice show normal T-cell development and
homeostasis. (A) Thymocytes were harvested from C57BL/6 mice and
stained with anti-CD4-PE, anti-CD8-TC, and either PNA directly conjugated to FITC (top) or biotinylated E. cristigalli agglutinin (ECA)
and streptavidin-FITC (bottom). Cells were gated on PNAhi (left) or
PNAlo (right) to indicate populations with terminal O-linked Gal␤13GalNAc or ECAhi (left) or ECAlo (right) to indicate terminal Nlinked Gal␤1-4GlcNAc. (B) Thymocytes from mMGL⫹/⫺ and
mMGL⫺/⫺ littermates were stained with anti-CD4 and anti-CD8 and
analyzed by flow cytometry. (C) CD4SP (top) and CD8SP (bottom)
populations were analyzed for PNA binding between mMGL⫹/⫹ and
mMGL⫺/⫺ mice. (D) Thymocytes were cocultured for 16 h with
mMGL- or mock-transfected 3T6 fibroblasts, and the live cell recovery
of different subsets was determined by multiplying cell count by percentage of annexin V staining on gated populations. (E) Thymocytes
from C57BL/6 mice were harvested and cocultured with thioglycollateelicited macrophages from mMGL⫹/⫹ and mMGL⫺/⫺ mice in vitro.

cytes bearing potential ligands for mMGL, namely, unsialylated O-linked Gal␤1-3GalNAc, are located in the cortex,
whereas cells bearing this Gal/GalNAc receptor are segregated
in the medulla. In the spleen of wild-type mice, we found
sparse mMGL staining compared with Mac-1 (Fig. 2C), similar
to the staining found in liver (not shown). In contrast, mMGL
staining in skin (Fig. 2D) and lymph nodes (Fig. 2E) was at
least as frequent as Mac-1 staining. In the skin, abundant
staining was seen in the dermis, and in the lymph node there
was also abundant staining in the extrafollicular paracortex.
These results indicate that mMGL is differentially expressed in
Mac-1⫹ cells. It is definitely expressed on peritoneal macrophages; however, expression elsewhere is consistent with a
subpopulation of macrophages or mature dendritic cells. While
the antibody staining revealed by LOM14 is diminished in all
tissues from mMGL⫺/⫺ mice, the possibility remains that there
exists another cross-reactive mMGL-like molecule.

Normal lymphoid development and homeostasis in
mMGLⴚ/ⴚ mice. We examined mMGL-deficient mice for lymphoid development. Our initial hypothesis was that medullary
mMGL-expressing macrophages might regulate the developmental transition that occurs from the cortical, undersialylated
immature thymocytes to medullary, fully sialylated mature T
cells. This process can be monitored by analyzing thymocytes
stained with PNA to detect O-linked terminal Gal-GalNAc
and staining for CD4 and CD8 to detect the major thymic
subpopulations (Fig. 3A). Thymocytes were separately stained
with E. cristigalli agglutinin, which detects the terminal galactose present on N-linked branched glycoproteins (Fig. 3A).
With either of these lectins, we found that undersialylated
thymocytes in wild-type mice were mainly CD4⫹ CD8⫹, the
population found in the cortex, whereas the sialylated thymocytes were either CD4⫹ CD8⫺ (CD4SP) or CD4⫺ CD8⫹
(CD8SP), the mature populations found in the medulla.
We next sought to determine whether the absence of
mMGL-bearing macrophages would result in an altered cellularity within the thymus. Examination of thymuses from
mMGL⫹/⫺ and mMGL⫺/⫺ mice revealed that T-cell develop-
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ment appears normal in mMGL-deficient mice, with thymocytes having similar subpopulations of CD4⫹ CD8⫺ (CD4SP),
CD4⫺ CD8⫹ (CD8SP), and CD4⫹ CD8⫹ (DP) cells (Fig. 3B).
The number of PNA-high thymocytes in each of the subsets
was also determined. The data indicate that there is no significant increase in PNAhi thymocytes in the mature CD4SP and
CD8SP subsets (Fig. 3C). Likewise, development was normal
as detected by surface expression of CD3, CD5, and heatstable antigen (data not shown). Further, although variable,
the rate of death appeared to be unaltered as measured by
staining for apoptotic markers with annexin V, DiOC6, and
terminal deoxynucleotidyl transferase-mediated dUTP-biotin
nick end labeling (data not shown).
The thymus size of mMGL-deficient mice compared to heterozygous littermates seemed slightly increased in mice aged 8
to 16 weeks (9.8 [⫾4.5] ⫻ 107 cells, n ⫽ 27 [⫺/⫺] versus 8.4
[⫾3.6] ⫻ 107 cells, n ⫽ 33 [⫹/⫹]), but due to the variability
within each group, this difference was not statistically significant (P ⬎ 0.05, Student’s t test, unpaired). B-cell expression of
B220 was similar among wild-type and mMGL null mice, and
B-cell proliferation to anti-immunoglobulin M and lipopolysaccharide in vitro was normal (data not shown). We conclude
from these data that T-cell development is grossly unaltered
and that expression of mMGL is not required for normal T- or
B-cell development.
We also studied the function of mMGL with respect to the
induction of apoptosis in Gal/GalNAc-exposed CD4⫹ CD8⫹
thymocytes. In the first set of experiments, we showed that
fibroblasts transfected with mMGL would result in cell loss of
CD4⫹ CD8⫹ (cortical) but not CD4SP or CD8SP (medullary)
thymocytes (Fig. 3D).We then sought to determine whether
elicited peritoneal macrophages would mediate the loss of
thymocytes in an mMGL-dependent manner. Measuring cell
recovery, viability, and apoptotic indices, we found that macrophages do have a substantial effect on the recovery of thymocytes, but after extensive investigation, including numerous
separate trials, we did not find a significant difference between
macrophages from wild-type and mMGL-deficient mice (data
not shown). Thus, despite the ability of mMGL transfectants to
mediate thymocyte cell death in vitro and the demonstrated
large amounts of mMGL on peritoneal macrophages (Fig. 2A),
there was no indication that mMGL expression was required
for thymocyte cell death.
mMGL-deficient mice were also tested for T-cell responses
by measuring the cytotoxic T-cell response to major histocompatibility-disparate tumor cells. P815 tumor cells were injected
intraperitoneally into mMGL⫹/⫹ and mMGL⫺/⫺ mice. On day
10 of the response, CTL specific lysis was measured ex vivo
along with the expansion of CD8 T cells. The cytotoxic T-cell
responses of mMGL⫹/⫹ and mMGL⫺/⫺ mice were similar
(Fig. 4A). Similar expansion of CD8 T cells was also observed
(Fig. 4B). Both mMGL⫹/⫹ and mMGL⫺/⫺ T cells exhibited the
expression of activation markers, becoming CD44hi, CD62Llo,
and PNAhi (data not shown). In addition, we measured the
proportion of apoptotic T cells as measured by annexin V
during the time course of a T-cell response in vivo and again
found no significant differences in mice lacking mMGL on day
10 (Fig. 4C), day 12, or day 17 (data not shown). These results
indicate that CD8 T-cell responses do not rely on mMGL for
activation, effector function, or turnover of activated T cells.
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FIG. 4. Allogeneic cytotoxic T-cell response in mMGL⫹/⫹ and
mMGL⫺/⫺ mice. (A) P815 targets were cultured with lymphocytes
from the spleen, and CTL lysis was determined. mMGL-deficient mice
showed cytolytic activity similar to that in the wild type. (B) Expansion
of CD8 T cells after the in vivo response was similar between
mMGL⫹/⫹ and mMGL⫺/⫺ mice. (C) Percentage of annexin V⫹ CD8 T
cells was similar between mMGL⫹/⫹ and mMGL⫺/⫺ mice.

Elevated red blood cell counts but similar life span and
turnover. Mice were also subjected to extensive hematology
analysis, blood coagulation, and blood chemistry tests. Only
measures of erythrocyte content showed a statistically significant deviation from wild-type values. As shown in Table 1, red
blood cell counts, hemoglobin, hematocrit, and mean corpuscular volume were all slightly elevated in mMGL-deficient
mice. This was of potential interest because one model of
erythrocyte turnover is that erythrocytes lose sialic acid as a
consequence of aging, and it is possible that such aged erythrocytes would be scavenged by macrophages present in the
spleen and liver (9, 14, 34). While the mean differences noted
were statistically significant, the mMGL⫺/⫺ values still fell
within the normal range for mice. In addition, an analysis of
erythrocyte life span in vivo was carried out on mMGL⫹/⫹ and
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TABLE 1. Hematological analysis of mMGLa

Parameterb (U)

mMGL⫹/⫹ (n ⫽ 11)

mMGL⫹/⫺ (n ⫽ 10)

mMGL⫺/⫺ (n ⫽ 16)

Leukocytes (cells/l)
Neutrophils (%)
Lymphocytes (%)
Monocytes (%)
Eosinophils (%)
Basophils (%)
Erythrocytes (m/ml)
Hemoglobin (g/liter)
Hematocrit (%)
MCV (fl)
MCH (pg)
MCHC (g/liter)
RDW (%)
Platelets (103/l)
MPV (fl)

7,772.6 (697.67)
8.1 (2.02)
89.1 (2.39)
0.4 (0.18)
0.0 (0.00)
2.4 (0.42)
9.8 (0.15)
15.2 (0.16)
47.7 (0.52)
48.6 (0.36)
15.5 (0.10)
31.9 (0.10)
18.7 (0.22)
820.3 (48.4)
7.0 (0.17)

8,826.0 (848.83)
11.7 (1.55)
83.2 (1.64)
1.4 (0.24)
0.3 (0.12)
3.3 (0.25)
9.9 (0.13)
15.4 (0.18)
48.8 (0.54)
49.3 (0.39)
15.5 (0.12)
31.4 (0.13)
18.3 (0.45)
861.1 (55.8)
7.1 (0.14)

8,830.0 (730.08)
9.6 (1.24)
87.1 (1.42)
0.8 (0.21)
0.2 (0.08)
2.2 (0.22)
10.2 (0.09)
15.8 (0.12)
50.6 (0.41)
49.8 (0.35)
15.6 (0.10)
31.3 (0.10)
18.3 (0.18)
928.8 (29.7)
7.0 (0.09)

t test

Change (%)

0.044
0.009
0.000
0.032

⫹3.5
⫹3.8
⫹6.0
⫹2.4

0.001

⫺1.8

0.054

⫹13.2

a

Data for each test are listed with the standard error of the mean in parentheses.
MCV, mean cell volume; MCH, mean cell hemoglobin; MCHC, mean cell hemoglobin concentration; RDW, red cell distribution width; MPV, mean platelet
volume.
b

mMGL⫺/⫺ mice. Erythrocyte life spans averaged between
36.67 and 37.27 days, respectively (Fig. 5). We conclude that
there are only minor hematological consequences associated
with the loss of mMGL.
Complementation of ST3Gal-I deficiency. In mice lacking
ST3Gal-I (siat4a), there is a profound loss of CD8 T cells in the
periphery (23). In these mice, there is enhanced core 2 glycosylation, revealed by the antibody 1B11, and enhanced PNA
binding. Moreover, cross-linking with 1B11 on CD8 T cells
from these mice induced apoptosis (23). We considered the
possibility that a lack of ST3Gal-I revealed an unsialylated
O-linked Gal␤1-3GalNAc that could be bound by mMGLbearing macrophages in vivo. This, in turn, could cause crosslinking of undersialylated molecules and induce apoptosis. Under such circumstances, a deficiency in mMGL would be
predicted to complement the loss of CD8 T cells in ST3Gal-Ideficient mice.
Mice were crossed to produce ST3Gal-I⫹/⫺ controls and
either ST3Gal-I⫺/⫺ mMGL⫹/⫺ or ST3Gal-I⫺/⫺ mMGL⫺/⫺ littermates (Fig. 6). The number of CD8 T cells was enumerated
in the peripheral blood at 3 to 6 weeks of age. In addition, the
data were segregated for males and females. As shown in Fig.
6, there were approximately 11% CD8 T cells at all ages in
ST3Gal-I⫹/⫺ mice, whereas the percentage of CD8 T cells in
ST3Gal-I⫺/⫺ mice varied between 1 and 5%. The absence of
mMGL did not complement the level of CD8 T cells to wildtype levels, but there was a trend toward increased T-cell
numbers at all ages in double null mice. The difference between ST3Gal-I⫺/⫺ mMGL⫹/⫺ and ST3Gal-I⫺/⫺ mMGL⫺/⫺ in
females reached statistical significance at weeks 3 and 5 (P ⬍
0.05 and P ⬍ 0.01, respectively). However, we conclude that
mMGL minimally mediates the loss of CD8 T cells in ST3GalI⫺/⫺ mice. Either the loss of CD8 T cells in ST3Gal-I⫺/⫺ mice
occurs by a different mechanism entirely, or there is another
endogenous galactose-specific lectin that is functionally redundant with mMGL in this regard.
Evidence for multiple Gal␤1-3GalNAc lectins expressed on
macrophages. As a probe to examine Gal/GalNAc lectins
within lymphoid tissues, we used a biotinylated mucin known
as AFGP, a highly glycosylated polypeptide containing multiple O-linked Gal␤1-3GalNAc disaccharides. As shown in Fig.
7A and B, AFGP bound to cells located in the medulla of the

thymus (compared with the streptavidin control). To show the
specificity of this binding, serial sections of the thymus were
stained with AFGP-biotin and competed with Gal␤1-3GalNAc
or Gal␣1-3GalNAc. As shown in Fig. 7C-E, there was a specific
competition with Gal␤1-3GalNAc compared with Gal␣1-3GalNAc. Similar staining results in the thymus were found with a
biotinylated polyacrylamide-based polymer of Gal␤1-3GalNAc
(Gal␤1-3GalNAc-PAA) (data not shown).
To determine whether the lectin was present on macrophages, spleen sections were stained with biotinylated Gal␤13GalNAc-PAA or biotinylated anti-Mac-1, followed by alkaline phosphatase-labeled streptavidin (Fig. 8A). Similar to
anti-mMGL, staining with the Gal/GalNAc polymer was sparse
but definitely positive in the spleen compared with anti-Mac-1.
To determine whether this staining was dependent on mMGL,
sections from an mMGL⫺/⫺ mouse were also double-stained
with anti-Mac-1–FITC and Gal/GalNAc-PAA–rhodamine
(Fig. 8B). The pictures were taken separately and then merged.
The inset shows the AFGP labeling alone. As shown, there was
strong Gal/GalNAc probe binding despite the absence of
mMGL, and all of the Gal/GalNAc staining coincided with
Mac-1 staining. This indicates that the lectin detected by
AFGP or Gal␤1-3GalNAc-PAA is present on a small subpopulation of Mac-1-positive cells. Similar to mMGL itself, these
cells could be a subpopulation of macrophages or dendritic
cells. Preliminary evidence showed that this lectin-carbohydrate interaction may not be calcium dependent, as binding
occurred in the presence of EDTA. Thus, at least one putative
Gal/GalNAc binding molecule is most likely not a C-type lectin.
DISCUSSION
In this report we have described the production and characterization of mice deficient in the known macrophage galactose lectin mMGL. With these mice, we addressed three questions related to a potential role for mMGL in the recognition
of cell surface structures regulated by differential sialylation.
First, does mMGL regulate the maturation and progression of
undersialylated, cortical, CD4⫹ CD8⫹ thymocytes? Second,
does mMGL regulate the turnover of effector T cells that
become undersialylated subsequent to activation? Third, does
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FIG. 6. Effect of mMGL deficiency in ST3Gal-I-deficient mice.
ST3Gal-I mice were crossed to mMGL-deficient mice to examine the
role of mMGL in the CD8 T-cell loss in ST3Gal-I-deficient mice. Solid
squares represent ST3Gal-I⫹/⫺ mice, which show normal CD8 T-cell
numbers in the peripheral blood lymphocytes (PBL). Solid circles
represent ST3Gal-I⫺/⫺ mMGL⫹/⫺ mice, which show decreased numbers of CD8 T cells. Open circles show doubly deficient mice.
(Top) Female doubly deficient mice show a trend of increased CD8
T-cell numbers compared to ST3Gal-I-deficient mice, reaching statistical significance in female mice aged 3 and 5 weeks. (Bottom) Male
mice showed no statistically significant changes.
FIG. 5. Erythrocyte (RBC) turnover in mMGL⫹/⫹ and mMGL⫺/⫺
mice. Mean life span of red blood cells was determined in
(A) mMGL⫹/⫹ and (B) mMGL⫺/⫺ mice after biotinylation in vivo.
The mean erythrocyte life span was 36.67 days in mMGL⫹/⫹ mice,
versus 37.27 days in mMGL⫺/⫺ mice.

mMGL play a role in the turnover of red blood cells that lose
sialylation with age?
The development and selection of thymocytes are accompanied by a high rate of cell death, so that an estimated 98% of
the thymocytes produced in the thymus die prior to emigration
(31). The physiological mechanisms responsible for thymocyte
cell death are almost entirely uncharacterized (37). Several
receptor-ligand interactions have been proposed to participate
in thymocyte death (6, 16, 17, 22), but there are few examples
of targeted deletions that result in thymus hyperplasia (33).
Despite the many studies on the topic, there is yet no real
conceptual understanding of the signaling mechanisms that

distinguish positive and negative selection of developing thymocytes. As such, we wanted to study the possibility that differential sialylation during thymus development could be recognized by an endogenous lectin as a way of regulating the
emergence of mature T cells. From this and previous studies,
we conclude that neither the deletion of ST3Gal-I nor the
deletion of mMGL appears to have a substantial effect on
T-cell development (23).
The observation that activated T cells lose sialylation and
following expansion show significant apoptosis prompted us to
consider the possibility that an endogenous lectin could induce
death based on cross-linking of undersialylated molecules. This
mechanism would be consistent with the loss of CD8 T cells in
ST3Gal-I-deficient mice and the delay in death of antigenspecific effector CD8 T cells in CD43⫺/⫺ mice (Onami et al.,
unpublished data). We saw no differences in CD8 T cell numbers for mMGL⫹/⫹ versus mMGL⫺/⫺ mice following activation in vivo and similar numbers of apoptotic CD8 T cells in
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FIG. 7. Identification of Gal/GalNAc-specific lectin(s) distinct
from mMGL. (A) Sialic acid (SA) binding alone. (B) Gal␤1-3GalNAcPAA. (C to E) Serial sections were probed with (C) Gal␤1-3GalNAcPAA, (D) Gal␤1-3GalNAc-PAA plus Gal␤1-3GalNAc, and
(E) Gal␣1-3GalNAc plus Gal␣1-3GalNAc.

these mice as well. To determine whether an mMGL gene
inhibition could complement the targeted ST3Gal-I deficiency
in the loss of CD8 T cells, we produced mice deficient in both
genes. As shown, although there appeared to be a tendency
toward higher numbers of CD8 T cells in the mice lacking
mMGL, mMGL⫺/⫺ ST3Gal-I⫺/⫺ mice still showed a profound

MOL. CELL. BIOL.

FIG. 8. Gal/GalNAc-specific lectin(s) is macrophage restricted.
(A) Splenic sections from mMGL⫺/⫺ mice were probed with biotinylated Gal␤1-3GalNAc-PAA or anti-Mac-1 antibodies. Localized binding of the Gal␤1-3GalNAc-PAA probe was observed in the splenic red
pulp, and this correlated with Mac-1 staining. (B) Double staining of
splenic sections from mMGL-deficient mice with Gal␤1-3GalNAcPAA and Mac-1 revealed colocalization of the lectin to a Mac-1⫹ cell.
Gal␤1-3GalNAc-PAA binding was always seen on Mac-1 binding cells
but not the converse, suggesting that the lectin(s) is expressed on a
subpopulation of macrophages or mature dendritic cells.

CD8 T-cell deficiency. Therefore, we conclude that mMGL
cross-linking of undersialylated cell surface molecules is not
the predominant mechanism of cell loss in ST3Gal-I⫺/⫺ mice.
In addition to lymphocytes, erythrocytes undergo differential
sialylation. Experiments show that sialic acids are lost as eryth-

mMGL-DEFICIENT MICE

VOL. 22, 2002

rocytes undergo senescence (2, 4, 14). The role of sialic acids in
erythrocyte senescence is not understood, but one possibility is
that it constitutes one of the signals that target aged erythrocytes for destruction (9). We considered the possibility that
mMGL-bearing macrophages could recognize the undersialylated erythrocytes and execute their engulfment. There does
appear to be a difference in erythrocyte numbers in mMGL
mice (Table 1), but the biological significance is difficult to
discern. We did not find a statistically significant difference in
turnover rates, leading us to believe that the increases seen in
erythrocytes in mMGL⫺/⫺ mice may be explained by other
indirect effects. Moreover, mMGL expression is not abundant
in the spleen and liver, where erythrocyte turnover takes place
after desialylation.
With AFGP as a probe, we identified an additional macrophage lectin(s) or lectin-like activity that is specific for Gal␤13GalNAc but independent of mMGL. Binding of this lectin to
its ligand is not affected by EDTA, suggesting that binding is
not calcium dependent, and thus it is not a C-type lectin. In
future studies, this lectin can be characterized further by purifying galactose-specific binding proteins with cell lysates derived from mMGL null mice. We propose that this lectin may
play a functionally redundant role to mMGL and conclude
from our studies that mMGL expression is not required for
normal lymphoid homeostasis.
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